Post

New research · Ophthalmology
Current oncology (Toronto, Ont.) · 16h
ObservationalCurrent oncology (Toronto, Ont.) · 2025

Endoresection in Choroidal Melanoma: Outcomes of Intentional Incomplete Tumor Removal.

Alexander Anduaga-Beramendi, Marta Caminal-Caramés, Daniel Lorenzo … Josep M Caminal
Read paper
OphthalmologyObservational

Endoresection with intentional residual tumor gave 97% five-year survival in choroidal melanoma

Endoresection in Choroidal Melanoma: Outcomes of Intentional Incomplete Tumor Removal.

Alexander Anduaga-Beramendi … Josep M Caminal
Current oncology (Toronto, Ont.) · 2025
Purpose

This technique aims to reduce surgical morbidity, while preserving visual function and maintaining effective local tumor control and survival.

Methods

We conducted a retrospective observational study including 33 patients with choroidal melanoma treated between January 2017 and August 2024 at a single tertiary ocular oncology center in Spain.

n = 33 patients
97%
Results
97%
checked survival after surgery - higher means more patients alive at 5 years
n = 33 patients
More results

Patients underwent pars plana vitrectomy and endoresection leaving residual tumor followed by ruthenium-106 brachytherapy.

Visual acuity of 20/200 or better was preserved in 60.61% of patients.

The most frequent complications were retinal detachment (36.36%) and macular edema (45.45%).

More results

Cytogenetic analysis showed a significant association between chromosome 1p loss and both recurrence and metastasis ( p = 0.032).

“
Conclusion

Further studies are required to validate its long-term efficacy.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving